Detailed description sounds promising.
In this webinar, we will discuss tools and protocols for non-viral engineering of CAR-T cells and CAR-NK cells, reviewing data that show efficient gene editing and post-electroporation viability for both cell types. We will discuss a next-generation, universal CAR platform (OmniCAR) developed by Prescient Therapeutics with insights on efforts made to establish closed, GMP-compliant processes for manufacturing in a collaboration with Thermo Fisher Scientific....Speakers will showcase data incorporating a closed end-to-end cell manufacturing workflow utilizing Gibco™ CTS™ Dynacellect Magnetic Cell Separator, Gibco™ CTS™ Xenon™ Electroporation System, Gibco™ CTS™ Rotea™ Counterflow Centrifugation, and ancillary reagents.
and in true TF style the sign up wants to know which machines you want to buy. Hopefully after this colab the answer from many others will be whichever ones Prescient are using.
Detailed description sounds promising.In this webinar, we will...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.85M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.6¢ | $3.677K | 78.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 57148 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 190000 | 1 |
View Market Depth
| Last trade - 11.31am 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.7¢ |
Change
0.000 ( 1.88 %) |
||||
| Open | High | Low | Volume | ||
| 4.7¢ | 4.7¢ | 4.7¢ | 482 | ||
| Last updated 10.11am 06/05/2024 ? | |||||
| PTX (ASX) Chart |